Peripheral CD4+ naïve T cell remodeling and MMP1-associated inflammatory signatures in acute gouty arthritis - Report - MDSpire

Peripheral CD4+ naïve T cell remodeling and MMP1-associated inflammatory signatures in acute gouty arthritis

  • By

  • Peng Zhang

  • Fangjie Zhu

  • Yunting Xiao

  • Zhengdong Shen

  • Chunxiao Fan

  • Peifeng Ke

  • Yao Xu

  • Chenguang Zhan

  • Xin Li

  • Xiaodong Wu

  • Liyan Mei

  • Kaixin Gao

  • Haifang Du

  • Xiumin Chen

  • Yang Jiao

  • Runyue Huang

  • Maojie Wang

  • May 26, 2026

  • 0 min

Share

Remodeling of Peripheral CD4+ Naïve T Cells and Inflammatory Markers Associated with MMP1 in Acute Gouty Arthritis

Overview

This study investigates the role of peripheral CD4+ naïve T cell remodeling and inflammatory markers, particularly MMP1, in acute gouty arthritis (GA).

Background

Gouty arthritis is characterized by acute inflammatory episodes due to monosodium urate crystal deposition, leading to significant morbidity. Understanding the immune mechanisms involved, particularly the role of adaptive immunity, is important.

Data Highlights

Analysis TypeFindings
Mendelian RandomizationAssociations between immune traits and gout risk, including CD127⁺ CD4⁺ T cells
Mass CytometryExpansion and remodeling of CD4⁺ naïve T cells during acute flares
Plasma ProteomicsElevated MMP1 and S100A12 levels during acute flares
Recurrence Risk AnalysisMMP1 showed potential for 12-week recurrence risk stratification (AUC = 0.8533)

Key Findings

  • Mendelian randomization indicated associations between immune traits and gout risk.
  • CD4⁺ naïve T cells exhibited functional remodeling during acute flares.
  • Inflammatory transcriptional features were identified in CD4⁺ naïve T cells.
  • Plasma levels of MMP1 and S100A12 were elevated during acute flares.
  • MMP1 may mediate the relationship between serum uric acid and CD4⁺ naïve T cell abundance.

Clinical Implications

The findings indicate the role of MMP1 and CD4+ naïve T cell remodeling in acute gouty arthritis.

Conclusion

The study indicates that peripheral CD4+ naïve T cell remodeling and MMP1-associated inflammatory signatures are relevant in acute gouty arthritis.

Related Resources & Content

  1. Clinical Rheumatology, 2011 -- A Review of Gouty Arthritis Pathophysiology and Its Clinical Management Strategies
  2. Frontiers in Medicine, 2026 -- Associations of systemic immune-inflammation index and aggregate index of systemic inflammation with acute gouty arthritis in men: a cross-sectional study
  3. Frontiers in Immunology, 2026 -- Neutrophil extracellular traps in gout: from immune defense to pathological dynamic equilibrium
  4. 2020 American College of Rheumatology Guideline for the Management of Gout - PMC
  5. Frontiers in Immunology — Study on the pro-inflammatory injury of neutrophil extracellular traps in gouty nephropathy
  6. 2020 American College of Rheumatology Guideline for the Management of Gout - PMC
  7. Is colchicine prophylaxis required with start-low go-slow allopurinol dose escalation in gout? A non-inferiority randomised double-blind placebo-controlled trial - ScienceDirect
  8. The pathogenesis of gout: molecular insights from genetic, epigenomic and transcriptomic studies | Nature Reviews Rheumatology

Original Source(s)

Related Content